Amgen, Genzyme are developing new intracellular production methods

01/31/2013 | MIT Technology Review online

Genzyme and Amgen are pushing to develop cheaper and faster ways of manufacturing biological drugs inside cells. Amgen is working on a new process for protein production, while Genzyme is pursuing a concept called continuous manufacturing.

View Full Article in:

MIT Technology Review online

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Director of Governmental Programs
Bluegrass Family Health
Lexington, KY